Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinics in Laboratory Medicine|July 10, 2003
Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndromeGeorge J Knight, Glenn E PalomakiObstetrics and Gynecology|February 2, 2006
Comparing three screening strategies for combining first- and second-trimester Down syndrome markersGlenn E Palomaki, Klaus Steinort, George J Knight, et al.Prenatal Diagnosis|March 11, 2003
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markersGlenn E Palomaki, Louis M Neveux, George J Knight, et al.Clinical Chemistry|August 21, 2004
Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimesterGlenn E Palomaki, Louis M Neveux, George J Knight, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh seraGlenn E Palomaki, Louis M Neveux, George J Knight, et al.Clinical Chemistry|June 18, 2005
Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screeningGlenn E Palomaki, George J Knight, Louis M Neveux, et al.Seminars in Perinatology|August 18, 2005
Patient and health professional acceptance of integrated serum screening for Down syndromeGlenn E Palomaki, Edward M Kloza, James E Haddow, et al.Archives of Pathology & Laboratory Medicine|July 2, 2013
Screening for down syndrome in the United States: results of surveys in 2011 and 2012Glenn E Palomaki, George J Knight, Edward R Ashwood, et al.Archives of Pathology & Laboratory Medicine|March 2, 2005
A comparison of human chorionic gonadotropin- related components in fresh frozen serum with the proficiency testing material used by the College of American PathologistsGeorge J Knight, Glenn E Palomaki, George G Klee, et al.Archives of Pathology & Laboratory Medicine|November 4, 2010
Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndromeGlenn E Palomaki, George J Knight, Geralyn Lambert-Messerlian, et al.Pageof 2